Rethinking HCC – Grand Junction, CO
This live activity is focused on treatment strategies for patients with hepatocellular carcinoma (HCC).
This live activity is focused on treatment strategies for patients with hepatocellular carcinoma (HCC).
This program will review the use of CDK 4/6 inhibitors in the treatment of HR+/HER2-negative breast cancer and the management of treatment-related adverse events.